Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Azd1152-Hqpa Induces Growth Arrest and Apoptosis in Androgen-Dependent Prostate Cancer Cell Line (Lncap) Via Producing Aneugenic Micronuclei and Polyploidy Publisher Pubmed



Zekri A1 ; Ghaffari SH2 ; Ghanizadehvesali S2 ; Yaghmaie M2 ; Salmaninejad A1 ; Alimoghaddam K2 ; Modarressi MH1 ; Ghavamzadeh A2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Tumor Biology Published:2015


Abstract

Prostate cancer is the frequent non-cutaneous tumor with high mortality in men. Prostate tumors contain cells with different status of androgen receptor. Androgen receptor plays important roles in progression and treatment of prostate cancer. Aurora B kinase, with oncogenic potential, is involved in chromosome segregation and cytokinesis, and its inhibition is a promising anti-cancer therapy. In the present study, we aimed to investigate the effects of Aurora B inhibitor, AZD1152-HQPA, on survival and proliferation of androgen receptor (AR)-positive prostate cancer cells. LNCaP was used as androgen-dependent prostate cancer cell line. We explored the effects of AZD1152-HQPA on cell viability, DNA content, micronuclei formation, and expression of genes involved in apoptosis and cell cycle. Moreover, the expression of Aurora B and AR were investigated in 23 benign prostatic hyperplasia and 38 prostate cancer specimens. AZD1152-HQPA treatment induced defective cell survival, polyploidy, and cell death in LNCaP cell line. Centromeric labeling with fluorescence in situ hybridization (FISH) showed that the loss of whole chromosomes is the origin of micronuclei, indicating on aneugenic action of AZD1152-HQPA. Treatment of AZD1152-HQPA decreased expression of AR. Moreover, we found weak positive correlations between the expression of Aurora B and AR in both benign prostatic hyperplasia and prostate cancer specimens (r = 0.25, r = 0.41). This is the first time to show that AZD1152-HQPA can be a useful therapeutic strategy for the treatment of androgen-dependent prostate cancer cell line. AZD1152-HQPA induces aneugenic mechanism of micronuclei production. Taken together, this study provides new insight into the direction to overcome the therapeutic impediments against prostate cancer. © 2014, International Society of Oncology and BioMarkers (ISOBM).
Related Docs
1. Reactive Oxygen Species Generation and Increase in Mitochondrial Copy Number: New Insight Into the Potential Mechanism of Cytotoxicity Induced by Aurora Kinase Inhibitor, Azd1152-Hqpa, Anti-Cancer Drugs (2017)
2. The Potential Contribution of Micrornas in Anti-Cancer Effects of Aurora Kinase Inhibitor (Azd1152-Hqpa), Journal of Molecular Neuroscience (2018)
3. Inhibitor of Aurora Kinase B Induces Differentially Cell Death and Polyploidy Via Dna Damage Response Pathways in Neurological Malignancy: Shedding New Light on the Challenge of Resistance to Azd1152-Hqpa, Molecular Neurobiology (2016)
4. Significance of Azd1152 As a Potential Treatment Against Aurora B Overexpression in Acute Promyelocytic Leukemia, Annals of Hematology (2016)
5. Morphine Attenuated the Cytotoxicity Induced by Arsenic Trioxide in H9c2 Cardiomyocytes, Biological Trace Element Research (2016)
6. Enhanced Beta-Catenin Expression Is Associated With Recurrence of Papillary Thyroid Carcinoma, Endocrine Practice (2018)
Experts (# of related papers)
View all Related Experts
Seyed Hamidollah Ghaffari (4)
Mohammad Hossein Modarressi (1)